» Articles » PMID: 21806553

Robust Substrate Profiling Method Reveals Striking Differences in Specificities of Serum and Lung Fluid Proteases

Overview
Journal Biotechniques
Date 2011 Aug 3
PMID 21806553
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Proteases are candidate biomarkers and therapeutic targets for many diseases. Sensitive and robust techniques are needed to quantify proteolytic activities within the complex biological milieu. We hypothesized that a combinatorial protease substrate library could be used effectively to identify similarities and differences between serum and bronchoalveolar lavage fluid (BALF), two body fluids that are clinically important for developing targeted therapies and diagnostics. We used a concise library of fluorogenic probes to map the protease substrate specificities of serum and BALF from guinea pigs. Differences in the proteolytic fingerprints of the two fluids were striking: serum proteases cleaved substrates containing cationic residues and proline, whereas BALF proteases cleaved substrates containing aliphatic and aromatic residues. Notably, cleavage of proline-containing substrates dominated all other protease activities in both human and guinea pig serum. This substrate profiling approach provides a foundation for quantitative comparisons of protease specificities between complex biological samples.

Citing Articles

Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.

Bottger R, Hoffmann R, Knappe D PLoS One. 2017; 12(6):e0178943.

PMID: 28575099 PMC: 5456363. DOI: 10.1371/journal.pone.0178943.


Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.

Hmmier A, OBrien M, Lynch V, Clynes M, Morgan R, Dowling P BBA Clin. 2017; 7:97-104.

PMID: 28331811 PMC: 5357681. DOI: 10.1016/j.bbacli.2017.03.001.


Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.

Jambunathan K, Watson D, Endsley A, Kodukula K, Galande A FEBS Lett. 2012; 586(16):2507-12.

PMID: 22750443 PMC: 3500622. DOI: 10.1016/j.febslet.2012.06.015.


Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability.

Findeisen P, Costina V, Yepes D, Hofheinz R, Neumaier M J Exp Clin Cancer Res. 2012; 31:56.

PMID: 22682081 PMC: 3780806. DOI: 10.1186/1756-9966-31-56.


Substrate specifity profiling of the Aspergillus fumigatus proteolytic secretome reveals consensus motifs with predominance of Ile/Leu and Phe/Tyr.

Watson D, Feng X, Askew D, Jambunathan K, Kodukula K, Galande A PLoS One. 2011; 6(6):e21001.

PMID: 21695046 PMC: 3117871. DOI: 10.1371/journal.pone.0021001.

References
1.
Vallor A, Kirkpatrick W, Najvar L, Bocanegra R, Kinney M, Fothergill A . Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother. 2008; 52(7):2593-8. PMC: 2443907. DOI: 10.1128/AAC.00276-08. View

2.
Salzameda N, Barbieri J, Janda K . Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors. Bioorg Med Chem Lett. 2009; 19(20):5848-50. PMC: 2753755. DOI: 10.1016/j.bmcl.2009.08.079. View

3.
Yi J, Kim C, Gelfand C . Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res. 2007; 6(5):1768-81. DOI: 10.1021/pr060550h. View

4.
Satchi-Fainaro R, Puder M, Davies J, Tran H, Sampson D, Greene A . Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med. 2004; 10(3):255-61. DOI: 10.1038/nm1002. View

5.
Gaggar A, Jackson P, Noerager B, OReilly P, McQuaid D, Rowe S . A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol. 2008; 180(8):5662-9. PMC: 3998665. DOI: 10.4049/jimmunol.180.8.5662. View